Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles

Open Access

Peer-reviewed

Research Article

Peggy Sekula ,

* E-mail: ps@imbi.uni-freiburg.de

Affiliation Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center–University of Freiburg, Freiburg, Germany

http://orcid.org/0000-0003-2263-447X

⨯
Susan Mallett,

Affiliation Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯
Douglas G. Altman,

Affiliation Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom
⨯
Willi Sauerbrei

Affiliation Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center–University of Freiburg, Freiburg, Germany
⨯

Reader Comments (0)

Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Medical journals
Is the Subject Area "Medical journals" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Research reporting guidelines
Is the Subject Area "Research reporting guidelines" applicable to this article?

Thanks for your feedback.
Scientific publishing
Is the Subject Area "Scientific publishing" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Medicine and health sciences
Is the Subject Area "Medicine and health sciences" applicable to this article?

Thanks for your feedback.